Skip to main content
Log in

Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol andN-acetyl-4-S-cysteaminylphenol

  • Original Articles
  • Melanoma, Tyrosinase Cysteaminylphenol, Thymidylate Synthase
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The rationale for melanoma-specific antitumor agents containing phenolic amines is based in part on the ability of the enzyme tyrosinase to oxidize these prodrugs to toxic intermediates. The phenolic amine compounds 4-S-cysteaminylphenol (4-S-CAP) andN-acetyl-4-S-cysteaminylphenol (N-Ac-4-S-CAP) inhibited in situ thymidylate synthase activity in pigmented melanoma cell lines but had little or no effect on nonpigmented and nonmelanoma cell lines. Theophylline, a cyclic adenosine monophosphate (cAMP) phosphodiesterase inhibitor, increased tyrosinase activity and potentiated the inhibition of in situ thymidylate synthase by N-Ac-4-S-CAP. The inhibition of in situ thymidylate synthase by both drugs in pigmented melanoma cells correlated with the inhibition of DNA synthesis and cell growth and was not due to an indirect effect caused by inhibition of the enzyme dihydrofolate reductase. 4-S-CAP inhibition of thymidylate synthase activity in cell free extracts required oxidation of the drug. In the presence of tyrosinase, the concentration causing a 50% inhibition of thymidylate synthase activity (IC50) in cell-free extacts was <10 μM, but no inhibition was observed in its absence, even at a drug concentration of 500 μM. Two reducing agents, dithioerythritol and glutathione, effectively blocked the inhibition of thymidylate synthase by oxidized 4-S-CAP. In pigmented melanoma cells containing the enzyme tyrosinase, the quinone-mediated mechanism of inhibition of DNA synthesis via inhibition of thymidylate synthase may be uniquely important in the expression of phenolic amine cytotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alena F, Jimbow K, Ito S (1990) Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. Cancer Res 50:3743

    Google Scholar 

  2. Balzarini J, De Clerq E (1982) 5-Substituted 2-deoxyuridine: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase. Biochem Pharmacol 22:3673

    Google Scholar 

  3. Balzarini J, De Clerq E (1984) Strategies for the measurement of the inhibitory effects of thymidine analogs on the inhibitory effects of thymidylate synthetase in intact murine leukemia cells. Biochim Biophys Acta 785:36

    Google Scholar 

  4. Boekelheide K, Graham DG, Mize PD, Koo EH (1980) Melanocytotoxicity and the mechanism of activation of γ-L-glutaminyl-4-hydroxybenzene. J Invest Dermatol 75:322

    Google Scholar 

  5. Cohen SS (1971) On the nature of thymineless death. Ann NY Acad Sci 186:292

    Google Scholar 

  6. Felix CC, Hyde JS, Sarna T, Sealy RC (1978) Melanin photoreactions in aerated media: electron spin resonance evidence for production of superoxide and hydrogen peroxide. Biochem Biophys Res Commun 84:335

    Google Scholar 

  7. Fidler IJ (1975) Biological behaviour of malignant cells correlated to their survival in vivo. Cancer Res 35:1

    Google Scholar 

  8. FitzGerald GB, Wick MM (1986) Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes. Biochem Pharmacol 35:271

    Google Scholar 

  9. Friedkin M (1973) Thymidylate synthetase. Adv Enzymol 38:235

    Google Scholar 

  10. Goulian M, Bleile B, Tsang BY (1980) Methotrexate-induced misincorporation of uracil in DNA. Proc Natl Acad Sci USA 77:1956

    Google Scholar 

  11. Halaban R, Lerner AB (1977) Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. Exp Cell Res 108:119

    Google Scholar 

  12. Ingraham HA, Dickey L, Goulian M (1986) DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. Biochemistry 25:3225

    Google Scholar 

  13. Ito S, Jimbow K (1987) Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy. Cancer Res 47:3278

    Google Scholar 

  14. Ito S, Kato T, Ishikawa K, Kasuga T, Jimbow K (1987) Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminyl-phenol to melanocytes. Biochem Pharmacol 36:2007

    Google Scholar 

  15. Ito S, Kato T, Fujita K (1988) Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol 37:1707

    Google Scholar 

  16. Jackson RC (1978) The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine and 3-deazauridine. J Biol Chem 253:7440

    Google Scholar 

  17. Kable EPW, Favier D, Parsons PG (1989) Sensitivity of human melanoma cells toL-dopa andD, L-buthionine (S, R)-sulfoximine. Cancer Res 49:2327

    Google Scholar 

  18. Lomax MIS, Greenberg RG (1967) An exchange between the hydrogen atom on carbon 5 of deoxyuridylate and water catalyzed by thymidylate synthetase. J Biol Chem 242:1302

    Google Scholar 

  19. Mead JAR, Vendetti JM, Schrecker AW, Goldin A, Keresztesy JC (1963) The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice. Biochem Pharmacol 12:371

    Google Scholar 

  20. Miura S, Ueda T, Jimbow K, Ito S, Fujita K (1987) Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect. Arch Dermatol Res 279:219

    Google Scholar 

  21. Mojamdar M, Ichihashi I, Mishima Y (1983) Gamma-glutamyl-transpeptidase, tyrosinase, and 5-S-cysteinyldopa in melanoma cells. J Invest Dermatol 81:119

    Google Scholar 

  22. Padgette SR, Herman HH, Han JH, Pollock SH, May SW (1984) Antihypertensive activities of phenylaminoethyl sulfides, a class of synthetic substrates for dopamine B-hydroxylase. J Med Chem 27:1354

    Google Scholar 

  23. Prezioso JA, FitzGerald G, Wick MM (1990) Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. Pigment Cell Res 3:49

    Google Scholar 

  24. Reddy GPV (1982) Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase. Biochem Biophys Res Commun 109:908

    Google Scholar 

  25. Roberts D (1966) An isotopic assay for thymidylate synthetase. Biochemistry 5:3546

    Google Scholar 

  26. Rode W, Scanlon KJ, Moroson BA, Bertino JR (1980) Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J Biol Chem 255:1305

    Google Scholar 

  27. Sjostrom DA, Forsdyke DR (1974) Isotope-dilution analysis of ratelimiting steps and pools affecting the incorporation of thymidine and deoxycytidine into cultured thymus cells. Biochem J 138:253

    Google Scholar 

  28. Statford IJ, Stephens MA (1989) The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. Int J Radia Oncol Biol Phys 16:973

    Google Scholar 

  29. Yalowich JC, Kalman TI (1985) Rapid determination of thymidylate synthase activity and its inhibition in intact leukemia cells in vitro. Biochem Pharmacol 34:2319

    Google Scholar 

  30. Yamada I, Seki S, Ito S, Suzuki S, Matsubara O, Kusuga T (1991) The killing effect of 4-S-cysteaminylphenol, a newly synthesized melanin precursor, on B16 melanoma cell lines. Br J Cancer 63:187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by a grant from the Claude Worthington Benedum Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prezioso, J.A., Wang, N. & Bloomer, W.D. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol andN-acetyl-4-S-cysteaminylphenol. Cancer Chemother. Pharmacol. 30, 394–400 (1992). https://doi.org/10.1007/BF00689968

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689968

Keywords

Navigation